March 08, 2021
Article
Both diabetes types lead to severely elevated blood sugar levels that eventually cause a host of possible complications, including loss of limbs and eyesight, kidney damage, diabetic coma, and death.
March 04, 2021
Investigators have found that the evolutionary sequence of insulin has become stuck at the edge of impaired production, limiting its ability to adapt to obesity and rendering most people vulnerable to type 2 diabetes.
March 03, 2021
The study found patients who used mHealth applications had better health outcomes and were able to regulate their health behavior more effectively than patients who did not use these apps, in addition to fewer hospital visits and lower medical costs.
March 01, 2021
Systemic inflammation associated with RA may contribute to the risk of a patient developing type 2 diabetes.
February 27, 2021
The National DPP is an evidence-based lifestyle change program designed to delay or prevent the onset of type 2 diabetes among adults with prediabetes.
February 19, 2021
Patients with diabetes have a higher risk of cardiovascular disease and heart failure.
February 18, 2021
The study measured immune responses from individuals genetically predisposed to developing T1D to naturally occurring insulin and hybrid insulin peptides.
February 16, 2021
One-third of study participants treated with semaglutide lost at least 20% (46 pounds) of their baseline weight, which is a common reduction for many patients who have had bariatric surgery in the 1 to 3 years following their procedure.
February 15, 2021
The objective of the study was to determine the impact of goldenseal on specific drug transporters, proteins that facilitate absorption or expulsion of drug molecules in different tissues, such as the intestine, liver, and kidney.
February 12, 2021
The two paired trials evaluated sotagliflozin, a drug that inhibits SGLT2 and SGLT1, according to a study published in The New England Journal of Medicine.
